[08/18/2017 03:42:57 ق.ظ] [۱۳۹۶ جمعه ۲۷ مرداد] [عضويت در پورتال] [ورود مديران]
Skip Navigation Links

   

What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?

Keshvari M, Alavian SM, Sharafi H.

Clinics (Sao Paulo). 2014 Feb;69(2):152.

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies.

Pournik O, Alavian SM, Ghalichi L, Seifizarei B, Mehrnoush L, Aslani A, Anjarani S, Eslami S.

Hepat Mon. 2014 Jan 3;14(1):e15167.

GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study.

Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, Motedayen MH, Sazmand A.

Hepat Mon. 2013 Dec 30;13(12):e15342.

Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran.

Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H.

Hepat Mon. 2013 Dec 16;13(12):e14324.

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C.

Keshvari M, Pouryasin A, Behnava B, Sharafi H, Hajarizadeh B, Alavian SM.

Aliment Pharmacol Ther. 2014 Feb;39(3):343.  Can we Include Genetic Variants with High Linkage Disequilibrium into a Multiple Logistic Model?

Keshvari M, Sharafi H, Hajarizadeh B, Alavian SM.

Liver Int. 2014 Jan 8.  Lessons learned from past cholera epidemics, interventions which are needed today.

Lankarani KB, Alavian SM.

J Res Med Sci. 2013 Aug;18(8):630-1.  Sofosbuvir has come out of the magic box.

Alavian SM.

Hepat Mon. 2013 Dec 16;13(12):e16916.  Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study.

Mahdavi M, Amirrasouli H, Alavian SM, Behnava B, Kazerouni F, Keshvari M, Namaki S, Gholami Fesharaki M, Rahimipour H, Mohammadzade J, Zohrehbandian F, Mahdavipour F.

Hepat Mon. 2013 Nov 23;13(11):e11903.  The Role of Celiac Disease in Severity of Liver Disorders and Effect of a Gluten Free Diet on Diseases Improvement.

Rostami-Nejad M, Haldane T, Aldulaimi D, Alavian SM, Zali MR, Rostami K.

Hepat Mon. 2013 Oct 13;13(10):e11893.  Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein.

Motavaf M, Safari S, Saffari Jourshari M, Alavian SM.

Acta Virol. 2013;57(4):389-96.  Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran.

Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Nasseri S.

Hepat Mon. 2013 Sep 1;13(9):e13699.  Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran.

Mehrazmay A, Alavian SM, Moradi-Lakeh M, Mokhtari Payam M, Hashemi-Meshkini A, Behnava B, Miri SM, Karimi Elizee P, Tabatabaee SV, Keshvari M, Bagheri Lankarani K.

Hepat Mon. 2013 Sep 1;13(9):e10236.  Understanding of molecular pain medicine: genetic basis of variation in pain sensation and analgesia response.

Motavaf M, Safari S, Alavian SM.

Anesth Pain Med. 2013 Winter;2(3):104-6.  Oral conditions associated with hepatitis C virus infection.

Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P.

Saudi J Gastroenterol. 2013 Nov-Dec;19(6):245-51.  Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C.

Akbarzadeh Baghban A, Pourhoseingholi A, Zayeri F, Jafari AA, Alavian SM.

Biomed Res Int. 2013;2013:403151.  Evolutionary analysis of HBV "S" antigen genetic diversity in Iranian blood donors: a nationwide study.

Pourkarim MR, Sharifi Z, Soleimani A, Amini-Bavil-Olyaee S, Elsadek Fakhr A, Sijmons S, Vercauteren J, Karimi G, Lemey P, Maes P, Alavian SM, Van Ranst M.

J Med Virol. 2014 Jan;86(1):144-55.  Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?

Abbasinazari M, Behnava B, Panahi Y, Hajhossein Talasaz A, Salimi S, Keshvari M, Mehrnoush L, Karim Elizee P, Gholami Fesharaki M, Asgharinia M, Alavian SM.

Hepat Mon. 2013 Aug 12;13(8):e11138.  Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures.

Ghamari S, Alavian SM, Rizzetto M, Olivero A, Smedile A, Khedive A, Alavian SE, Zolfaghari MR, Jazayeri SM.

Hepat Mon. 2013 Aug 16;13(8):e6731.

Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis.

Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, Sadigh ZA, Alavian SM.

Hepat Mon. 2013 Aug 5;13(8):e11290.

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users.

Alavian SM, Mirahmadizadeh A, Javanbakht M, Keshtkaran A, Heidari A, Mashayekhi A, Salimi S, Hadian M.

Hepat Mon. 2013 Aug 17;13(8):e12411.


Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.

Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N.

Hepat Mon. 2013 Jul 8;13(7):e8743.


HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly?

Amini-Bavil-Olyaee S, Tacke F, Alavian SM.

Hepat Mon. 2013 Jul 1;13(7):e13048.


Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD).

Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L.

Hepat Mon. 2013 Jul 13;13(7):e10943.


Prevention of hepatitis a virus infection, need to vaccinate or not?

Elizee PK, Alavian SM.

Int J Prev Med. 2013 Aug;4(8):863-5.


 Mutational Analysis of HBs Ag-Positive Mothers and Their Infected Children despite Immunoprophylaxis.

Ghaziasadi A, Alavian SM, Norouzi M, Fazeli Z, Jazayeri SM.

Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):352-60.


 Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran.

Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, Aghasadeghi MR.

Hepat Mon. 2013 May;13(5):e10134.


 Direct medical care costs associated with patients diagnosed with chronic HCV.

Ashtari S, Vahedi M, Pourhoseingholi MA, Karkhane M, Kimiia Z, Pourhoseingholi A, Safaee A, Moghimi-Dehkordi B, Zali MR, Alavian SM.

Hepat Mon. 2013 Apr 28;13(5):e8415.


Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: a data-mining approach.

Pournik O, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S.

Hepat Mon. 2013 May 23;13(5):e7652.


Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation.

Ghamar Chehreh ME, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H, Amin M, Zali MR, Alavian SM.

Hepat Mon. 2013 May 8;13(5):e7382.


Hepatitis delta: the rediscovery.

Rizzetto M, Alavian SM.

Clin Liver Dis. 2013 Aug;17(3):475-87.


Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.

Alavian SM, Tabatabaei SV, Behnava B, Rizzetto M.

J Res Med Sci. 2012 Oct;17(10):967-74.


Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran.

Khedive A, Sanei-Moghaddam I, Alavian SM, Saberfar E, Norouzi M, Judaki M, Ghamari S, Jazayeri SM.

Arch Iran Med. 2013 Jul;16(7):385-9.


Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.

Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Judaki MA, Ghamari S, Daram M, Mahabadi M, Fazeli Z, Goodarzi Z, Poortahmasebi V, Jazayeri SM.

J Viral Hepat. 2013 Jul;20(7):494-501.


Collecting blood just from voluntary repeated blood donors is the wisdom strategy in Vietnam.

Alavian SM.

Indian J Med Res. 2013 Apr;137(4):813.


Evaluation of Knowledge and Practice of Hairdressers in Women's Beauty Salons in Isfahan About Hepatitis B, Hepatitis C, and AIDS in 2010 and 2011.

Ataei B, Shirani K, Alavian SM, Ataie M.

Hepat Mon. 2013 Mar 6;13(3):e6215.


Hepatitis B virus infection: need for more attention in hemodialysis patients.

Einollahi B, Alavian SM.

Saudi J Kidney Dis Transpl. 2013 May;24(3):587-8.


Probiotic as a novel treatment strategy against liver disease.

Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, Khani S, Alavian SM.

Hepat Mon. 2013 Feb 25;13(2):e7521.


Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.

Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM.

Hepat Mon. 2013 Jan 20;13(1):e6712.


Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains.

Samimi-Rad K, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, Eslami SM, Zamani F, Magnius L, Alavian SM, Norder H.

Hepat Mon. 2013 Jan 23;13(1):e7699.


Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M.

Hepat Mon. 2013 Jan;13(1):e8210.


Distribution of hepatitis C virus genotypes in Iranian chronic infected patients.

Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F.

Hepat Mon. 2013 Jan;13(1):e7991.


Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals.

Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Salimi S, Mehrnoush L, Fatemi A.

Hepat Mon. 2012 Dec;12(12):e8387.


Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature.

Mahboobi N, Porter SR, Karayiannis P, Alavian SM.

J Gastrointestin Liver Dis. 2013 Mar;22(1):79-86.


Intra-familial Transmission of Hepatitis B virus Infection in Zahedan.

Hatami H, Salehi M, Sanei E, Khosravi S, Alavian SM.

Iran Red Crescent Med J. 2013 Jan;15(1):4-8.


Health in the Islamic Republic of Iran, challenges and progresses.

Lankarani KB, Alavian SM, Peymani P.

Med J Islam Repub Iran. 2013 Feb;27(1):42-9.


Psychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis.

Ghasemi S, Kabir A, Ansari Jafari M, Jalali M, Amini A, Faghihi-Kashani AH, Alavian SM.

Hepat Mon. 2012 Dec;12(12):e7650.


Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M.

Iran J Radiol. 2012 Nov;9(4):167-77.


Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study.

Keyvani H, Agah S, Kabir A, Alavian SM.

Ann Hepatol. 2013 Mar; 12(2):213-9.


Can we accurately assess liver fibrosis with fibroscan using fewer valid measurements?

Pournik O, Alavian SM, Eslami S.

Yonsei Med J. 2013 Mar 1; 54(2):541-2.


Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection.

Sayyad B, Alavian SM, Najafi F, Mokhtari Azad T, Ari Tabarestani MH, Shirvani M, Behnava B, Afshrian M, Vaziri S, Janbakhsh AR, Mansouri F, Kaviani Sh.

Iran Red Crescent Med J. 2012 Oct; 14(10):623-30.


Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study.

Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, Abolghasemi H.

Int J Prev Med. 2012 Nov; 3(11):770-5.


Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran.

Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, Alavian S, Judaki M, Ghamari S, Namazi A, Rahimnia R, Khedive A, Jazayeri S.

Iran J Public Health. 2012; 41(3):104-11. Epub 2012 Mar 31.


Celiac disease and abnormal liver function test.

Rostami Nejad M, Alavian SM.

Int J Prev Med. 2012 Oct; 3(10):745-6.


High Rate of Virological Response to Peginterferon α-2a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C.

Alavi Moghaddam M, Zali MR, Aalaei Andabili SH, Derakhshan F, Miri SM, Alavian SM.

Iran Red Crescent Med J. 2012 Aug; 14(8):466-9.


Letter to the editor: the increasing hepatitis a incidence in Korea: is it possible within a limited time?

Elizee PK, Alavian SM, Miri SM.

J Prev Med Public Health. 2012 Sep; 45(5):329-30.


Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial.

Sayad B, Alavian SM, Najafi F, Soltani B, Shirvani M, Janbakhsh A, Mansouri F, Afsharian M, Vaziri S, Alikhani A, Bashiri H.

Hepat Mon. 2012 Sep; 12(9):e6234. doi: 10.5812/hepatmon.6234.


Real response to therapy in chronic hepatitis C virus patients: a study from iran.

Namazee N, Sali S, Asadi S, Shafiei M, Behnava B, Alavian SM.

Hepat Mon. 2012 Sep; 12(9):e6151. doi: 10.5812/hepatmon.6151.


Occult Hepatitis B (OBH) in Clinical Settings.

Alavian SM, Miri SM, Hollinger FB, Jazayeri SM.

Hepat Mon. 2012 Aug; 12(8):e6126. doi: 10.5812/hepatmon.6126.


Principles of Meta-analysis should be Well Understood.

Aalaei-Andabili SH, Alavian SM.

Obes Surg. 2012 Dec; 22(12):1926-7.


Persistence of anti-HBs antibody in children whom vaccinated during infantile period and need to booster needs more discussion.

Alavian SM.

Eur J Pediatr. 2012 Oct 7.


Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C.

Motavaf M, Safari S, Alavian SM.

J Viral Hepat. 2012 Nov; 19(11):757-65.


Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.

Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM.

Transpl Infect Dis. 2012 Oct; 14(5):445-51.


HCV genotypes distribution pattern in India.

Bokharaei-Salim F, Alavian SM.

Indian J Med Res. 2012 Aug; 136(2):306-7.


Seronegative anti-hepatitis C virus antibody in hemodialysis patients.

Alavian SM.

Hemodial Int. 2012 Sep 4.


Reply to: "Obscure clinical implication of occult hepatitis B virus infection by perinatal transmission despite prophylaxis with hepatitis B vaccination and HBIG".

Jazayeri SM, Alavian SM.

J Hepatol. 2012 Dec; 57(6):1401-2.


Important steps for a reliable meta-analysis.

Aalaei-Andabili SH, Alavian SM.

Lancet Infect Dis. 2012 Sep; 12(9):663.


Occult hepatitis B in thalassemia: a need for further study.

Alavian SM.

J Infect Dev Ctries. 2012 Aug 21; 6(8):650-1.


On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in Iran.

Alavian SM.

Int J Prev Med. 2012 Jul; 3(7):437-9.


Hepatitis B virus and HIV coinfections can be interpreted in different ways.

Alavian SM.

J Infect Chemother. 2012 Aug 11.


Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases.

Aalaei-Andabili SH, Mehrnoush L, Salimi S, Shafiei M, Alavian SM.

Hepat Mon. 2012 Jun; 12(6):408-10.


Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy.

Tabatabaei SV, Alavian SM, Keshvari M, Behnava B, Miri SM, Karimi Elizee P, Zamani F, Amini Kafiabad S, Gharehbaghian A, Hajibeigy B, Lankarani KB.

Hepat Mon. 2012 Jun; 12(6):372-81.


Risk factors of viral hepatitis: yet to explore.

Bozorgi SH, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, Kargar-Fard H, Sadri M, Alavian SM.

Transfus Apher Sci. 2012 Oct; 47(2):145-9.


Seroepidemiology of HBV infection in South-East of iran; a population based study.

Salehi M, Alavian SM, Tabatabaei SV, Izadi Sh, Sanei Moghaddam E, Amini Kafi-Abad S, Gharehbaghian A, Khosravi S, Abolghasemi H.

Iran Red Crescent Med J. 2012 May; 14(5):283-8.


Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update.

Alavian SM, Taheri S.

Iran J Kidney Dis. 2012 Jul; 6(4):236-54.


HBsAg variants: Diagnostic-escape and diagnostic dilemma.

Alavian SM, Carman WF, Jazayeri SM.

J Clin Virol. 2012 Jul 10.


Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran.

Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M.

Hepat Mon. 2012 May; 12(5):339-43.


Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis.

Aalaei-Andabili SH, Alavian SM.

Vaccine. 2012 Aug 17; 30(38):5595-602.


HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM.

Iran Red Crescent Med J. 2011 Dec; 13(12):855-62.


Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.

Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F.

Arch Virol. 2012 Oct; 157(10):1959-65.


Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.

Alavian SM, Aalaei-Andabili SH.

Hepat Mon. 2012 Apr; 12(4):244-52.


Occult hepatitis B virus infection among hemodialysis patients.

Alavian SM.

Hepat Mon. 2012 Apr; 12(4):242-3.


Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma.

Alavian SM, Miri SM, Jazayeri SM.

Minerva Gastroenterol Dietol. 2012 Jun; 58(2):167-78.


High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG.

Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM.

J Hepatol. 2012 Sep; 57(3):515-21.


The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran.

Ghaziasadi A, Ziaee M, Norouzi M, Malekzadeh R, Alavian SM, Saberfar E, Judaki MA, Ghamari S, Khedive A, Namazi A, Rahimnia R, Jazayeri SM.

Acta Med Iran. 2012; 50(4):265-72.


Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran.

Samimi-Rad K, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, Salari H.

East Mediterr Health J. 2012 Mar; 18(3):227-35.


Halothane: how should it be used in a developing country?

Mahboobi N, Esmaeili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM.

East Mediterr Health J. 2012 Feb; 18(2):159-64.


Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in Qom province, center of Iran.

Ghadir MR, Belbasi M, Heidari A, Sarkeshikian SS, Kabiri A, Ghanooni AH, Iranikhah A, Vaez-Javadi M, Alavian SM.

Hepat Mon. 2012 Mar; 12(3):205-8.


Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response.

Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Mehrnoush L, Salimi S, Kheradvar O.

Hepat Mon. 2012 Mar; 12(3):190-5.


Hepatitis B immune globulin in liver transplantation prophylaxis: an update.

Dindoost P, Jazayeri SM, Alavian SM.

Hepat Mon. 2012 Mar; 12(3):168-76.


Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, Kabiri A, Ghanooni AH, Iranikhah A, Alavian SM.

Hepat Mon. 2012 Feb; 12(2):112-7.


Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management.

Shafiei M, Alavian SM.

Hepat Mon. 2012 Feb; 12(2):73-6.


Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not?

Nejad MR, Alavian SM.

Bratisl Lek Listy. 2012; 113(4):251.


Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients.

Jazayeri SM, Alavian SM.

Curr HIV Res. 2012 Apr; 10(3):245-6.


Commentary on "risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States".

Alavian SM, Jazayeri SM.

Am J Gastroenterol. 2012 Apr; 107(4):635.


High-quality meta-analyses are required for development of evidence in medicine.

Aalaei-Andabili SH, Alavian SM.

J Infect Dis. 2012 May 1; 205(9):1472.


Intravenous drug use and hepatitis C virus in iran.

Zobeiri M, Adibi P, Alavian SM.

Hepat Mon. 2012 Jan; 12(1):9-10.


RNA interference: a promising approach for the treatment of viral hepatitis.

Motavaf M, Alavian SM.

Hepat Mon. 2012 Jan; 12(1):7-8.


Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran.

Sayad B, Anvari FA, Alavian SM, Norouzi M, Hamzelooie M, Shirvani M, Pourhoseingholi A, Khedive A, Ghamari S, Judaki MA, Jazayeri SM.

Minerva Gastroenterol Dietol. 2012 Mar; 58(1):9-18.



Transmission of HBV infection from mothers HBsAg positive to infants need to more attention.

Alavian SM.

J Clin Virol. 2012 Jun;54(2):201.


Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.

Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei Andabili SH.

Hepat Mon. 2011 Dec;11(12):960-7.


IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients.

Sharafi H, Alavian SM.

Hepat Mon. 2011 Dec;11(12):958-9.


Herbal medicine and liver disease, for any conclusion we need to do more studies.

Alavian SM.

J Res Med Sci. 2011 Jul;16(7):974-5.


Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis.

Alavian SM, Tabatabaei SV, Behnava B.

J Viral Hepat. 2012 Feb;19(2):88-93.


One swallow doesn't bring spring, reply to Khamesipour et al.

Alavian SM.

Transfus Apher Sci. 2012 Feb;46(1):103.


Oral fluid and hepatitis A, B and C: a literature review.

Mahboobi N, Porter SR, Karayiannis P, Alavian SM.

J Oral Pathol Med. 2012 Aug;41(7):505-16.


Iranian dental students' knowledge of hepatitis B virus infection and its control practices.

Alavian SM, Mahboobi N, Mahboobi N, Savadrudbari MM, Azar PS, Daneshvar S.

J Dent Educ. 2011 Dec; 75(12):1627-34.


Seroprevalence of hepatitis B and C infection markers among children and adolescents in the southern Brazilian region.

Alavian SM.

Rev Inst Med Trop Sao Paulo. 2011 Nov-Dec; 53(6):347.


Optimal duration of treatment for HCV genotype 1 infection in slow responders: a meta-analysis.

Alavian SM, Tabatabaei SV, Behnava B, Mahboobi N.

Hepat Mon. 2011 Aug;11(8):612-9.


Virus- triggered autophagy in viral hepatitis - possible novel strategies for drug development.

Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, Los M, Ghavami S.

J Viral Hepat. 2011 Dec;18(12):821-30.


Re: Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen-We need to work much harder to control hepatitis B virus infection in developing countries.

Alavian SM.

Sultan Qaboos Univ Med J.


Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings.

Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, Keramati MR, Abdollahzade S, Taba Taba Vakili S.

Hepat Mon. 2011 Jun; 11(6):452-8.


IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report.

Mahboobi N, Behnava B, Alavian SM.

Hepat Mon. 2011 May;11(5):386-8.


Liver complications in celiac disease.

Zali MR, Rostami Nejad M, Rostami K, Alavian SM.

Hepat Mon. 2011 May;11(5):333-41.


The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation.

Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B.

Hepat Mon. 2011 Apr;11(4):247-54.


Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society.

Alavian SM, Mahboobi N, Mahboobi N.

Hepat Mon. 2011 Feb;11(2):99-102.


Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV.

Alavian SM, Miri SM.

Hepat Mon. 2011 Feb;11(2):67-8.


Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.

Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM.

Hepat Mon. 2011 Jan;11(1):3-6.


Successful exclusion of blood-borne viral disease in blood donors.

Ramezani H, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM.

Eur J Intern Med. 2011 Dec;22(6):e71-4.


Confidential unit exclusion and blood safety.

Alavian SM.

Sao Paulo Med J. 2011;129(5):359-60.


HBeAg negativity is not equal to the presence of pre core mutations in chronic hepatitis B patients.

Jazayeri SM, Alavian SM.

Saudi Med J. 2011 Nov;32(11):1206.


Hepatitis B vaccination in hemodialysis patients: different points of view for conclusion.

Alavian SM.

J Bras Nefrol. 2011 Jul-Sep;33(3):389-90.


The impact of HBV vaccination on Brazilian adolescents requires more attention.

Alavian SM, Aalaei-Andabili SH.

Cad Saude Publica. 2011 Oct;27(10):2070.


Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons.

Alavian SM.

Rev Soc Bras Med Trop. 2011 Oct;44(5):652.


Commentary on: Treatment of HCV infection in chronic kidney disease.

Alavian SM.

Nefrologia. 2011;31(5):607; author reply 607-8.


Hepatitis a in developed country, the result should interpret carefully.

Alavian SM.

Gut Liver. 2011 Sep;5(3):395-6.


Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients.

Alavian SM, Miri SM, Tabatabaei SV, Keshvari M, Behnava B, Elizee PK, Mahboobi N, Lankarani KB.

Gut Liver. 2011 Sep;5(3):348-55.


Other views of occult hepatitis B in Hepatitis C infected patients.

Alavian SM, Jazayeri SM.

Eur J Intern Med. 2011 Oct;22(5):e67-8.


 

 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


Skip Navigation Links
پژوهشگاهExpand <a href='?ObjId=1&PageId=3208'>پژوهشگاه</a>
قطب علمی آموزشی تروماExpand <a href='?ObjId=1&PageId=2462'>قطب علمی آموزشی تروما</a>
رياست دانشگاهExpand <a href='?ObjId=1&PageId=8'>رياست دانشگاه</a>
نمایندگی ولی فقیه Expand <a href='?ObjId=1&PageId=90'>نمایندگی ولی فقیه  </a>
معاونت ها Expand <a href='?ObjId=1&PageId=170'>معاونت ها </a>
دانشكده‌هاExpand <a href='?ObjId=1&PageId=191'>دانشكده‌ها</a>
بيمارستان‌هاExpand <a href='?ObjId=1&PageId=195'>بيمارستان‌ها</a>
مراکز تحقيقاتي غير مصوبExpand <a href='?ObjId=1&PageId=218'>مراکز تحقيقاتي غير مصوب</a>
مراکر تحقيقاتي مصوبExpand <a href='?ObjId=1&PageId=200'>مراکر تحقيقاتي مصوب</a>